drugset / Trial / NCT02986906

Perineural Injection Therapy for Ulnar Neuropathy at Elbow

NCT02986906

Completed 36 enrolled Tri-Service General Hospital (TSGH)
RandomizedParallel-groupDouble-blindTreatment

Summary

Ulnar neuropathy at elbow (UNE) is the second common peripheral entrapment neuropathy. Although many conservative managements of UNE, the effectiveness of these methods are unsatisfied especial the moderate degree of UNE. Recently, ultrasound-guided perineural injection therapy (PIT) with 5% dextrose is progressively applicated for clinical treatment for entrapment neuropathy. However, current studies have not proved the effects of PIT on peripheral neuropathy because these studies enrolled small number of patients and lacked controlled design. We design a randomized, double-blind, controlled trail to assess the effect after ultrasound-guided PIT with 5% dextrose in patients with mild and moderate UNE.

Timeline

Start
2017-03-01
Primary completion
2019-10-30
Completion
2019-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject 5% dextrose Unknown 5 % Other
Comparator Triamcinolone Other / unclassified 30 mg Other

Indications